Eric Sung

Eric Sung

Company: Fate Therapeutics

Job title: Associate Scientist – In Vivo Pharmacology

Seminars:

Discussion/Q&A 10:40 am

Read more

day: Day Two

In Vivo Screens in Mouse Tumor Models Treated with Pools of Edited CAR-T Cells to Identify the Next Generation of iPSC Derived Immunotherapies for Cancer 9:00 am

Introduction to Fate’s iPSC Derived Immunotherapy Platform Novel multiplexed approach to generate pools of engineered CAR-T clones with different edits for combinatorial testing in vitro and in vivo Using genomics to screen pools of edited CAR-T in mouse tumor models to identify winning clones with specific editsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.